Given the lack of data on the role of PCSK9 in patients with IBD and the well-known presence of chronic low-grade inflammation in them, the aim of our study was to evaluate PCSK9 serum levels in patients with UC stratified according to disease activity by objective markers of inflammation. This evidence concerns the gene PCSK9 and inflammatory bowel disease.